Author: Kalup Alexander
Covered California’s small employer insurance program is growing, but a private-sector competitor is growing faster. CaliforniaChoice has 12,070 employers in its program and 218,648 enrollees. That’s up from 11,500 employers and 150,000 members last August. By comparison, Covered California has 2,289 employers and 15,633 enrollees, up from 1,7000 employers and 11,500 members in August. Both ...
The largest publicly run health plan in the nation, L.A. Care, will allow customers who do not have traditional bank accounts to pay their health insurance premiums with cash. One in four Americans who were previously uninsured and eligible for federal insurance subsidies do not have a bank account, relying instead on pre-paid debit cards, ...
Open enrollment may have ended in February, but the state's health insurance exchange has had a busy spring.
Several Nevada Republicans are trying to scrap the Silver State Health Insurance Exchange launched as part of President Barack Obama's health care overhaul, saying the program is expensive, suffered a rocky start and is another example of federal overreach.
How did a Reno collections agent end up in collections himself?
Nearly 80 percent of Nevadans who selected a qualified health plan through the state exchange paid for the insurance this month, officials said.
Mark Morgan, 48, president of the company's California business since 2013, will depart April 24.
Conservative objections over spending are raising doubts over whether the U.S. Senate can quickly approve legislation fixing the Medicare physician payment system, in a possible setback for Republicans keen to show they can get things done.
As consumers increasingly are being asked to pay a larger share of their health bills, a coalition of insurers, pharmaceutical companies, and provider and consumer advocacy groups launched Thursday a new push for greater transparency regarding the actual costs of services.
U.S. spending on prescription medicines jumped 13 percent to $374 billion in 2014, the biggest percentage increase since 2001, as demand surged for expensive new breakthrough hepatitis C treatments, a report released on Tuesday showed.